Similar low rates of HCV recurrence in HCV/HIV- and HCV-infected participants who achieved SVR after DAA treatment: Interim results from the ACTG A5320 Viral Hepatitis C Infection long-term Cohort Study (V-HICS)

on behalf of the VHICS Study Team

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Hepatitis C virus (HCV) recurrence rates were similar between those with HCV/HIV co-infection (0.35/100 person-years) and HCV infection (0.42/100 person-years). Low rates of recurrence likely represent enrollment of an HIV population at low risk for recurrence. Care should be taken not to label all HCV/HIV co-infected patients as being at high risk for HCV recurrence.

Original languageEnglish (US)
Article numberofy103
JournalOpen Forum Infectious Diseases
Volume5
Issue number6
DOIs
StatePublished - Jun 1 2018

Keywords

  • Direct acting antivirals
  • HIV
  • Hepatitis C
  • Recurrence

ASJC Scopus subject areas

  • Oncology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Similar low rates of HCV recurrence in HCV/HIV- and HCV-infected participants who achieved SVR after DAA treatment: Interim results from the ACTG A5320 Viral Hepatitis C Infection long-term Cohort Study (V-HICS)'. Together they form a unique fingerprint.

  • Cite this